Psychiatry and Neurology, Neurology · West Hollywood, CA
NPI
1881743748
Since 2007
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8727 Beverly Blvd Ste B
West Hollywood, CA, 90048
Phone (310) 474-9595
Groups this clinician bills Medicare through
Medicare paid, 2024
$777K
37,939 services
Medicare patients, 2024
98
Average age 65
Drug cost, 2024
$10.6M
1,923 prescriptions
Company payments, 2025
$536K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Regina R Berkovich was code J2323 (injection, natalizumab, 1 mg), 37,200 times for 14 patients. In total Regina R Berkovich billed 37,939 services in 16 codes, and Medicare paid $777K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2323 Injection, natalizumab, 1 mg | Office | 37,200 | 14 | $18.95 | $705K |
| 99215 Office E&M - Established | Office | 299 | 93 | $146.71 | $44K |
| 96365 Intravenous Infusion, Hydration | Office | 131 | 14 | $56.66 | $7,422 |
| 96366 Intravenous Infusion, Hydration | Office | 131 | 14 | $17.99 | $2,357 |
| 99214 Office E&M - Established | Office | 120 | 14 | $109.33 | $13K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 21 | 16 | $25.77 | $541 |
By year: 2022 $510K for 23,561 services; 2023 $649K for 28,256 services; 2024 $777K for 37,939 services.
Medicare prescription drug claims, 2024
In 2024, the drug Regina R Berkovich prescribed most often to Medicare patients was Dalfampridine Er (Dalfampridine), with 126 prescriptions and refills. In total Regina R Berkovich wrote 1,923 Medicare prescriptions that cost $10.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dalfampridine Er Dalfampridine | 126 | 208 | 25 | $53K |
| Privigen Immun Glob G(Igg)/Pro/Iga 0-50 | 117 | 117 | 12 | $1.3M |
| Gammagard Liquid Immun Glob G(Igg)/Gly/Iga Ov50 | 110 | 110 | 11 | $1.2M |
| Nuedexta Dextromethorphan Hbr/Quinidine | 109 | 135 | 19 | $210K |
| Baclofen Generic | 101 | 185 | 24 | $3,182 |
| Gabapentin Generic | 96 | 114 | 16 | $1,616 |
| Bafiertam Monomethyl Fumarate | 66 | 66 | Under 11 | $430K |
| Ampyra Dalfampridine | 58 | 72 | Under 11 | $297K |
| Zeposia Ozanimod Hydrochloride | 46 | 62 | Under 11 | $551K |
| Sodium Chloride 0.9 % Sodium Chloride | 45 | 45 | Under 11 | $475 |
| Vumerity Diroximel Fumarate | 45 | 45 | Under 11 | $365K |
| Acyclovir Generic | 42 | 77 | Under 11 | $463 |
| Panzyga Immun Glob G(Igg)-Ifas/Glycine | 41 | 41 | Under 11 | $388K |
| Kesimpta Pen Ofatumumab | 39 | 39 | Under 11 | $348K |
| Gamunex-C Immune Globul G/Gly/Iga Avg 46 | 39 | 39 | Under 11 | $443K |
Brand drugs: 935 claims; generic drugs: 988 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Regina R Berkovich $536K ($525K in general payments such as food, travel and fees and $12K for research) from 22 companies. The largest payer was EMD Serono, Inc. with $165K.
| Company | Payments | Amount |
|---|---|---|
| EMD Serono, Inc. MRK.DE | 73 | $165K |
| Biogen, Inc. BIIB | 105 | $99K |
| Mallinckrodt Hospital Products Inc. | 50 | $81K |
| Alexion Pharmaceuticals, Inc. AZN | 26 | $40K |
| Genzyme Corporation SNY | 20 | $40K |
| ANI Pharmaceuticals, Inc. ANIP | 40 | $27K |
| Amgen Inc. AMGN | 35 | $26K |
| TG Therapeutics, Inc. TGTX | 45 | $24K |
| E.R. Squibb & Sons, L.L.C. BMY | 11 | $17K |
| Novartis Pharmaceuticals Corporation NVS | 20 | $9,634 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.